A Randomized Controlled Pilot Study to Assess the Pharmacokinetics, Pharmacodynamics, and Closed-loop Efficacy of BC LisPram Compared to Rapid Insulin in Pump-treated Adults With Type 1 Diabetes
Latest Information Update: 07 Feb 2024
Price :
$35 *
At a glance
- Drugs Insulin lispro/pramlintide (Primary) ; Insulin lispro
- Indications Type 1 diabetes mellitus
- Focus Adverse reactions; Pharmacokinetics; Proof of concept
- 14 Feb 2022 Planned End Date changed from 1 Jan 2022 to 1 Jun 2022.
- 14 Feb 2022 Planned primary completion date changed from 1 Jan 2022 to 1 Jun 2022.
- 14 Feb 2022 Status changed from not yet recruiting to recruiting.